Human Immunology News Volume 10.06 | Feb 15 2022

    0
    76







    2022-02-15 | HIN 10.08


    Human Immunology News by STEMCELL Technologies
    Vol. 10.08 – 15 February, 2022
    TOP STORY

    Tryptophan-Derived Microbial Metabolites Activate the Aryl Hydrocarbon Receptor in Tumor-Associated Macrophages to Suppress Anti-Tumor Immunity

    Researchers examined the impact of aryl hydrocarbon receptor in tumor-associated macrophage function in pancreatic ductal adenocarcinoma.
    [Immunity]

    AbstractGraphical AbstractPress Release
    Stay up-to-date with the latest stem cell research by listening to the Stem Cell Podcast!
    PUBLICATIONSRanked by the impact factor of the journal

    Cancer-Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppression

    The authors reported that cancer cells with aberrant expression of glutamate decarboxylase 1 rewired glutamine metabolism for the synthesis of γ-aminobutyric acid (GABA)—a prominent neurotransmitter—in non-nervous tissues.
    [Nature Cell Biology]

    Abstract

    Surface Ig Variable Domain Glycosylation Affects Autoantigen Binding and Acts as Threshold for Human Autoreactive B Cell Activation

    Combining crystallography, glycobiology, and functional B cell assays allowed researchers to dissect key characteristics of variable domain glycans on human B cell biology.
    [Science Advances]

    Full Article

    Single-Cell Analysis of Human Glioma and Immune Cells Identifies S100A4 as an Immunotherapy Target

    Investigators reported an integrated analysis of 201,986 human glioma, immune, and other stromal cells at the single cell level.
    [Nature Communications]

    Full ArticleFull Article

    Single-Cell RNA Sequencing Reveals Induction of Distinct Trained Immunity Programs in Human Monocytes

    Researchers demonstrated cellular transcriptional programs to four different inducers of trained immunity in monocyte populations at single-cell resolution.
    [Journal of Clinical Investigation]

    Abstract

    SENP7 Senses Oxidative Stress to Sustain Metabolic Fitness and Antitumor Functions of CD8+ T Cells

    Investigators reported that SUMO-specific protease 7 (SENP7) sensed oxidative stress to maintain the CD8+ T cell metabolic state and antitumor functions.
    [Journal of Clinical Investigation]

    AbstractFull ArticleGraphical Abstract

    Single-Cell Isoform Analysis in Human Immune Cells

    The authors used R2C2 to sequence and demultiplex 12 million full-length cDNA molecules generated by the 10X Genomics platform from ~3000 peripheral blood mononuclear cells.
    [Genome Biology]

    Full Article

    CCR8-Targeted Specific Depletion of Clonally Expanded Treg Cells in Tumor Tissues Evokes Potent Tumor Immunity with Long-Lasting Memory

    Scientists found that multiclonal Tregs presented in tumor tissues predominantly expressed the chemokine receptor CCR8.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Activation and Expansion of T-Follicular Helper Cells in Chronic Lymphocytic Leukemia Nurselike Cell Co-Cultures

    In co-cultures from 28 different chronic lymphocytic leukemia patients, the authors detected an expansion of T-follicular helper cells based on PD-1, BCL6, and ICOS expression, with increased IL-21 and downmodulated CD40L surface expression.
    [Leukemia]

    Abstract

    RFX Transcription Factors Control a miR-150/PDAP1 Axis That Restrains the Proliferation of Human T Cells

    Researchers found that in primary human memory T helper lymphocytes, miR-150 was the most abundantly expressed miRNA, and its expression decreased drastically upon activation, suggesting regulatory roles.
    [PLoS Biology]

    Full Article

    Differential Localization and Limited Cytotoxic Potential of Duodenal CD8+ T Cells

    Scientists examined the spatial localization, phenotype, and function of CD8+ T cells in the human duodenal tissue from people living with HIV and healthy controls.
    [JCI Insight]

    Full ArticleGraphical Abstract

    A New kCa3.1 Channel Activator SKA-346 Boosts T Cell Antitumor Response in the Immune Suppressive Microenvironment

    The authors demonstrated that T cells exposed to high-e dose-dependently accumulated [K+]e intracellularly.
    [Biophysical Journal]

    Abstract
    REVIEWS

    Control of Immunity via Nutritional Interventions

    Scientists discuss recent evidence and emerging concepts supporting the idea that our newfound relationship with nutrition in industrialized countries has fundamentally altered the way in which our immune system is wired.
    [Immunity]

    Full Article
    INDUSTRY AND POLICY NEWS

    Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer

    Intellia Therapeutics, Inc., a company focused on developing curative therapies leveraging CRISPR-based technologies, and ONK Therapeutics Ltd., a company dedicated to developing optimally engineered NK cell therapies to treat cancer, announced a licensing and collaboration agreement.
    [Intellia Therapeutics, Inc.]

    Press Release

    Active Biotech Enters into Global Patent License Agreement with Oncode Institute for Tasquinimod in Myelofibrosis

    Active Biotech announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents relating to the use of tasquinimod and other inhibitors of S100 for use in treatment of myelofibrosis.
    [Active Biotech]

    Press Release

    PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer

    PDS Biotechnology Corporation announced the initiation of an Investigator-Initiated Trial, MC200710, for PDS0101 alone or in combination with the checkpoint inhibitor, KEYTRUDA®, in patients with HPV-associated oropharyngeal cancer at high risk of recurrence.
    [PDS Biotechnology Corporation]

    Press Release
    FEATURED EVENT

    Cell Symposium: Viruses in Health and Disease

    March 19 – 22, 2022
    Sitges, Spain

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – B Cells Immunity cSCC

    Imperial College London – London, England, United Kingdom

    Postdoctoral Scientist – Cellular Immunology/T Cell Therapy

    TU Dresden – Dresden, Germany

    Research Scientist – T Cell Stimulation

    Babraham Institute – Babraham, England, United Kingdom

    Research Association – Myeloma Cancer Cells

    Imperial College London – London, England, United Kingdom

    Research Associate – Molecular Biologist

    King’s College London- London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter